In this article

The production line of Covid-19 vaccine at a workshop of the Beijing-based Sinovac Life Sciences, affiliated with Sinovac Biotech, on June 1, 2021 in Beijing, China.

Costa Rican health authorities on Wednesday said that after studying the available clinical studies they had decided to reject the delivery of Sinovac Biotech's Covid-19 vaccine for the time being, saying it was not effective enough.

Earlier this month however, Uruguay released real-world data on the impact of Sinovac's vaccine among its population that showed it was over 90% effective in preventing intensive care admissions and deaths.

In this article